litlas
Log inCreate account

Peter J. Whitehouse

Active 1978–2022

65
Papers
19,232
Citations
61
h-index
65
i10-index

Citations

Citations per year for Peter J. Whitehouse1978: 1 citations1980: 2 citations1981: 4 citations1982: 14 citations1983: 38 citations1984: 51 citations1985: 61 citations1986: 82 citations1987: 68 citations1988: 96 citations1989: 92 citations1990: 77 citations1991: 79 citations1992: 87 citations1993: 55 citations1994: 73 citations1995: 66 citations1996: 92 citations1997: 93 citations1998: 73 citations1999: 105 citations2000: 149 citations2001: 117 citations2002: 117 citations2003: 166 citations2004: 143 citations2005: 150 citations2006: 142 citations2007: 175 citations2008: 189 citations2009: 191 citations2010: 188 citations2011: 205 citations2012: 159 citations2013: 154 citations2014: 149 citations2015: 162 citations2016: 103 citations2017: 137 citations2018: 102 citations2019: 300 citations2020: 245 citations2021: 311 citations2022: 206 citations2023: 152 citations2024: 241 citations2025: 130 citations2026: 8 citations1979: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,431 citing papers, 33% of this breakdownUnited Kingdom: 637 citing papers, 8.7% of this breakdownChina: 394 citing papers, 5.4% of this breakdownGermany: 371 citing papers, 5% of this breakdownCanada: 359 citing papers, 4.9% of this breakdownItaly: 344 citing papers, 4.7% of this breakdownAustralia: 253 citing papers, 3.4% of this breakdownFrance: 223 citing papers, 3% of this breakdownNetherlands: 205 citing papers, 2.8% of this breakdownSpain: 199 citing papers, 2.7% of this breakdownSweden: 188 citing papers, 2.6% of this breakdownJapan: 158 citing papers, 2.1% of this breakdown
0%33%Other 21.7%

Institutions

Fields

  • Medicine60.4%
  • Neuroscience18.5%
  • Biochemistry, Genetics and Molecular Biology9.8%
  • Computer Science2.8%
  • Psychology2.6%
  • Health Professions1.7%
  • Other4.2%

Topics

  • Dementia and Cognitive Impairment Research12.4%
  • Alzheimer's disease research and treatments9.1%
  • Cholinesterase and Neurodegenerative Diseases4.4%
  • Neuroscience and Neuropharmacology Research3%
  • Memory and Neural Mechanisms2.5%
  • Functional Brain Connectivity Studies2.5%
  • Other66.1%

Coauthors

All papers

Open in search
  1. Mild cognitive impairment

    Authors: Serge Gauthier, ‌Barry Reisberg, Michael Zaudig, Ronald C. Petersen, Karen Ritchie, Karl Broich, Sylvie Belleville, Henry Brodaty, David A. Bennett, Howard Chertkow, Jeffrey L. Cummings, Mony J. de Leon, Howard Feldman, Mary Ganguli, Harald Hampel, Philip Scheltens, Mary C. Tierney, Peter J. Whitehouse, Bengt Winblad - The Lancet 2006 cited by 3,865

  2. Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

    Authors: Peter J. Whitehouse, Donald L. Price, Arthur W. Clark, Joseph T. Coyle, Mahlon R. DeLong - Annals of Neurology 1981 cited by 1,747

  3. Practice parameter: Management of dementia (an evidence-based review) [RETIRED]

    Authors: Rachelle S. Doody, J E Stevens, C. Beck, Richard Dubinsky, Jeffrey Kaye, Lisa P. Gwyther, Richard C. Mohs, L. J. Thal, Peter J. Whitehouse, Steven T. DeKosky, Jeffrey L. Cummings - Neurology 2001 cited by 1,722

  4. Disclosure ofAPOEGenotype for Risk of Alzheimer's Disease

    Authors: Robert C. Green, J. Scott Roberts, L. Adrienne Cupples, Norman Relkin, Peter J. Whitehouse, Tamsen Brown, Susan LaRusse Eckert, Melissa Barber Butson, A. Dessa Sadovnick, Kimberly A. Quaid, Clara Chen, Robert Cook‐Deegan, Lindsay A. Farrer - New England Journal of Medicine 2009 cited by 554

  5. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease

    Authors: Yoshihisa Kitamura, Shun Shimohama, Wataru Kamoshima, Takashi Ota, Yasuji Matsuoka, Yasuyuki Nomura, Mark A. Smith, George Perry, Peter J. Whitehouse, Takashi Taniguchi - Brain Research 1998 cited by 269

  6. The neuropathology of aminergic nuclei in Alzheimer's disease

    Authors: Richard M. Zweig, Christopher A. Ross, John C. Hedreen, Cynthia Steele, J. E. Cardillo, Peter J. Whitehouse, Marchshal F. Folstein, Donald L. Price - Annals of Neurology 1988 cited by 441

  7. Basal forebrain neurons in the dementia of Parkinson disease

    Authors: Peter J. Whitehouse, John C. Hedreen, Charles L. White, Donald L. Price - Annals of Neurology 1983 cited by 532

  8. Evaluation of Dementia

    Authors: David Geldmacher, Peter J. Whitehouse - New England Journal of Medicine 1996 cited by 232

  9. Making the Case for the Accelerated Withdrawal of Aducanumab

    Authors: Peter J. Whitehouse, Vikas Saini - Journal of Alzheimer s Disease 2022 cited by 18

  10. Treatment of agitation in AD

    Authors: Linda Teri, Rebecca G. Logsdon, Elaine R. Peskind, Murray A. Raskind, Myron Weiner, Rochelle E. Tractenberg, Norman L. Foster, Lon S. Schneider, Mary Sano, Peter J. Whitehouse, Pierre N. Tariot, Alan M. Mellow, Alexander P. Auchus, Michael Grundman, Ronald G. Thomas, Kimberly Schafer, L. J. Thal - Neurology 2000 cited by 330

  11. Prevalence, recognition, and implications of mental impairment among hemodialysis patients

    Authors: Ashwini R. Sehgal, Scott F. Grey, Peter B. DeOreo, Peter J. Whitehouse - American Journal of Kidney Diseases 1997 cited by 272

  12. Making the Case for Accelerated Withdrawal of Aducanumab

    Authors: Peter J. Whitehouse, Sam Gandy, Vikas Saini, Daniel R. George, Eric B. Larson, G. Caleb Alexander, Jerry Avorn, Shannon Brownlee, Cameron J. Camp, Howard Chertkow, Adriane Fugh‐Berman, Robert Howard, Aaron S. Kesselheim, Kenneth M. Langa, George Perry, Edo Richard, Lon S. Schneider - Journal of Alzheimer s Disease 2022 cited by 40

  13. Vinpocetine for cognitive impairment and dementia

    Authors: Szabolcs Szatmári, Peter J. Whitehouse - Cochrane Database of Systematic Reviews 2003 cited by 149

  14. Assessing Patterns of Agitation in Alzheimerʼs Disease Patients with the Cohen-Mansfield Agitation Inventory

    Authors: Elisabeth Koss, Myron Weiner, Christopher Ernesto, Jiska Cohen‐Mansfield, Steven H. Ferris, Michael Grundman, Kimberly Schafer, Mary Sano, Leon J. Thal, Ronald G. Thomas, Peter J. Whitehouse - Alzheimer Disease & Associated Disorders 1997 cited by 143

  15. Ethical issues in early diagnosis and prevention of Alzheimer disease

    Authors: Peter J. Whitehouse - Dialogues in Clinical Neuroscience 2019 cited by 41

  16. A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease

    Authors: Kenneth L. Davis, L. J. Thal, E. Gamzu, Ch Davis, Robert F. Woolson, S. Gracon, David A. Drachman, Lon S. Schneider, Peter J. Whitehouse, Toni M. Hoover, John C. Morris, Claudia H. Kawas, David S. Knopman, Nancy L. Earl, Vinod Kumar, Rachelle S. Doody - New England Journal of Medicine 1992 cited by 627

  17. Changing perspectives regarding late-life dementia

    Authors: Majid Fotuhi, Vladimir Hachinski, Peter J. Whitehouse - Nature Reviews Neurology 2009 cited by 291

  18. Health‐Related Resource Use and Costs in Elderly Adults with and without Mild Cognitive Impairment

    Authors: Carolyn W. Zhu, Mary Sano, Steven H. Ferris, Peter J. Whitehouse, Marian B. Patterson, Paul Aisen - Journal of the American Geriatrics Society 2013 cited by 80

  19. Complex visual disturbances in Alzheimer's disease

    Authors: Mario F. Mendez, María Andreina Méndez, Richard J. Martin, Kathleen A. Smyth, Peter J. Whitehouse - Neurology 1990 cited by 337

  20. Abnormalities of the nucleus basalis in Down's syndrome

    Authors: Manuel F. Casanova, Lary C. Walker, Peter J. Whitehouse, Donald L. Price - Annals of Neurology 1985 cited by 202

  21. Differential diagnosis of Alzheimer's disease

    Authors: David Geldmacher, Peter J. Whitehouse - Neurology 1997 cited by 122

  22. Alzheimer Disease and Associated Disorders

    Authors: Stephen G. Post, Peter J. Whitehouse - Alzheimer Disease & Associated Disorders 1992 cited by 462

  23. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease

    Authors: Errol B. De Souza, Peter J. Whitehouse, Michael J. Kuhar, Donald L. Price, Wylie Vale - Nature 1986 cited by 254

  24. Genetic Risk Assessment for Adult Children of People With Alzheimer’s Disease: The Risk Evaluation and Education for Alzheimer’s Disease (REVEAL) Study

    Authors: J. Scott Roberts, L. Adrienne Cupples, Norman Relkin, Peter J. Whitehouse, Robert C. Green, for the REVEAL (Risk Evaluation and Education for Alzheimer’s Disease) Study Group - Journal of Geriatric Psychiatry and Neurology 2005 cited by 148